Distributed Networks of Databases Analyzed Using Common Protocols and/or Common Data Models

[1]  John F. Steiner,et al.  Sustaining Research Networks: the Twenty-Year Experience of the HMO Research Network , 2014, EGEMS.

[2]  Olaf Klungel,et al.  Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0 , 2017, Pharmacoepidemiology and drug safety.

[3]  W Katherine Yih,et al.  Active Surveillance for Adverse Events: The Experience of the Vaccine Safety Datalink Project , 2011, Pediatrics.

[4]  E. Weintraub,et al.  Risk of Guillain-Barré Syndrome following quadrivalent human papillomavirus vaccine in the Vaccine Safety Datalink. , 2017, Vaccine.

[5]  Kevin R. Fahey.  The Pioneering Role of the Vaccine Safety Datalink Project (VSD) to Advance Collaborative Research and Distributed Data Networks , 2015, EGEMS.

[6]  Matthew Wise,et al.  Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis , 2011, Neuroepidemiology.

[7]  M. Schuemie,et al.  Combining electronic healthcare databases in Europe to allow for large‐scale drug safety monitoring: the EU‐ADR Project , 2011, Pharmacoepidemiology and drug safety.

[8]  D. Madigan,et al.  Evaluating the impact of database heterogeneity on observational study results. , 2013, American journal of epidemiology.

[9]  M. Reichman,et al.  Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs , 2016, Annals of Internal Medicine.

[10]  Yea-Huei Kao Yang,et al.  Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries , 2015, Pharmacoepidemiology and drug safety.

[11]  Kenneth K C Man,et al.  Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis , 2016, Expert opinion on drug safety.

[12]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[13]  Roger Baxter,et al.  The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety. , 2014, Vaccine.

[14]  Tracy A. Lieu,et al.  The Cardiovascular Research Network: A New Paradigm for Cardiovascular Quality and Outcomes Research , 2008, Circulation. Cardiovascular quality and outcomes.

[15]  W Katherine Yih,et al.  Intussusception risk after rotavirus vaccination in U.S. infants. , 2014, The New England journal of medicine.

[16]  Sengwee Toh,et al.  A Query Workflow Design to Perform Automatable Distributed Regression Analysis in Large Distributed Data Networks , 2018, EGEMS.

[17]  S Toh,et al.  Successful Comparison of US Food and Drug Administration Sentinel Analysis Tools to Traditional Approaches in Quantifying a Known Drug‐Adverse Event Association , 2016, Clinical pharmacology and therapeutics.

[18]  Aziz A. Boxwala,et al.  A system to build distributed multivariate models and manage disparate data sharing policies: implementation in the scalable national network for effectiveness research , 2015, J. Am. Medical Informatics Assoc..

[19]  Bradley Malin,et al.  Design and implementation of a privacy preserving electronic health record linkage tool in Chicago , 2015, J. Am. Medical Informatics Assoc..

[20]  Patrick B. Ryan,et al.  Validation of a common data model for active safety surveillance research , 2012, J. Am. Medical Informatics Assoc..

[21]  N. Santanello,et al.  Sensitivity Analysis of Methods for Active Surveillance of Acute Myocardial Infarction Using Electronic Databases , 2015, Epidemiology.

[22]  Richard Platt,et al.  Launching PCORnet, a national patient-centered clinical research network , 2014, Journal of the American Medical Informatics Association : JAMIA.

[23]  Bruce Fireman,et al.  Influenza Vaccination and Mortality: Differentiating Vaccine Effects From Bias , 2009, American journal of epidemiology.

[24]  Bruce H Fireman,et al.  ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. , 2011, JAMA.

[25]  D. Singer,et al.  Outcomes of Dabigatran and Warfarin for Atrial Fibrillation in Contemporary Practice , 2017, Annals of Internal Medicine.

[26]  B. Hansen.  The prognostic analogue of the propensity score , 2008 .

[27]  Ruihua Yin,et al.  H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project. , 2011, American journal of preventive medicine.

[28]  Bruce H Fireman,et al.  Confounding Adjustment in Comparative Effectiveness Research Conducted Within Distributed Research Networks , 2013, Medical care.

[29]  L Charles Bailey,et al.  PCORnet Antibiotics and Childhood Growth Study: Process for Cohort Creation and Cohort Description. , 2018, Academic pediatrics.

[30]  R. Platt,et al.  Developing the Sentinel System--a national resource for evidence development. , 2011, The New England journal of medicine.

[31]  D L DeMets,et al.  Changing frequency of interim analysis in sequential monitoring. , 1989, Biometrics.

[32]  S. Anderson,et al.  The FDA's sentinel initiative—A comprehensive approach to medical product surveillance , 2016, Clinical pharmacology and therapeutics.

[33]  Nicholas Moore,et al.  The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology , 2017, Pharmacoepidemiology and drug safety.

[34]  Robert T. Chen,et al.  Active Surveillance of Vaccine Safety: A System to Detect Early Signs of Adverse Events , 2005, Epidemiology.

[35]  Andrew Bate,et al.  A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance , 2015, Drug Safety.

[36]  Marsha A Raebel,et al.  Design considerations, architecture, and use of the Mini‐Sentinel distributed data system , 2012, Pharmacoepidemiology and drug safety.

[37]  L. Smeeth,et al.  Risk of acute liver injury associated with use of antibiotics. Comparative cohort and nested case–control studies using two primary care databases in Europe , 2016, Pharmacoepidemiology and drug safety.

[38]  Roy Pardee,et al.  The HMO Research Network Virtual Data Warehouse: A Public Data Model to Support Collaboration , 2014, EGEMS.

[39]  Sebastian Schneeweiss,et al.  A basic study design for expedited safety signal evaluation based on electronic healthcare data , 2010, Pharmacoepidemiology and drug safety.

[40]  John W. Glasser,et al.  Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. , 1997, Pediatrics.

[41]  E. Roughead,et al.  Multi‐country rapid adverse drug event assessment: the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia study , 2013, Pharmacoepidemiology and drug safety.

[42]  M. Reichman,et al.  Prospective Postmarketing Surveillance of Acute Myocardial Infarction in New Users of Saxagliptin: A Population-Based Study , 2017, Diabetes Care.

[43]  Cartik R. Kothari,et al.  Phelan‐McDermid syndrome data network: Integrating patient reported outcomes with clinical notes and curated genetic reports , 2017, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[44]  Z. Shang,et al.  Using Statistics and Spatial Data Mining to Study Land Cover in Wyoming :Can We Predict Vegetation Types from Environmental Variables? , 2007 .

[45]  G. Requena,et al.  Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fractures , 2016, Pharmacoepidemiology and drug safety.

[46]  A. Garg,et al.  Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases , 2013, BMJ.

[47]  D. Rubin,et al.  Reducing Bias in Observational Studies Using Subclassification on the Propensity Score , 1984 .

[48]  K. K. Lan,et al.  Discrete sequential boundaries for clinical trials , 1983 .

[49]  R. Platt,et al.  Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy , 2016, Canadian Medical Association Journal.

[50]  W. Ray,et al.  Use of disease risk scores in pharmacoepidemiologic studies , 2009, Statistical methods in medical research.

[51]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .

[52]  Fang Zhang,et al.  Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study , 2014, BMJ : British Medical Journal.

[53]  Mia Gallagher,et al.  Stakeholders' views on data sharing in multicenter studies. , 2017, Journal of comparative effectiveness research.

[54]  Russell L. Rothman,et al.  The ADAPTABLE Trial and PCORnet: Shining Light on a New Research Paradigm , 2015, Annals of Internal Medicine.

[55]  Xiaodong Lin,et al.  Secure, Privacy-Preserving Analysis of Distributed Databases , 2007, Technometrics.

[56]  Lawrence H. Kushi,et al.  The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations , 2016, Cancer Causes & Control.

[57]  Roy Pardee,et al.  The National Patient-Centered Clinical Research Network (PCORnet) Bariatric Study Cohort: Rationale, Methods, and Baseline Characteristics , 2017, JMIR research protocols.

[58]  J. Robins,et al.  Estimating causal effects from epidemiological data , 2006, Journal of Epidemiology and Community Health.

[59]  Stephen E. Fienberg,et al.  "Secure" Log-Linear and Logistic Regression Analysis of Distributed Databases , 2006, Privacy in Statistical Databases.

[60]  R. Platt,et al.  Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy , 2007, Pharmacoepidemiology and drug safety.

[61]  Pierre Ernst,et al.  A Multicenter Observational Study of Incretin-based Drugs and Heart Failure. , 2016, The New England journal of medicine.

[62]  Sengwee Toh,et al.  Development and Application of Two Semi-Automated Tools for Targeted Medical Product Surveillance in a Distributed Data Network , 2017, Current Epidemiology Reports.

[63]  Sengwee Toh,et al.  Multivariable confounding adjustment in distributed data networks without sharing of patient‐level data , 2013, Pharmacoepidemiology and drug safety.

[64]  J. Gagne,et al.  Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System , 2018, Pharmacoepidemiology and drug safety.

[65]  Yu-Chuan Li,et al.  Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers , 2015, MedInfo.

[66]  Richard Platt,et al.  Is size the next big thing in epidemiology? , 2013, Epidemiology.

[67]  Sengwee Toh,et al.  Privacy-preserving Analytic Methods for Multisite Comparative Effectiveness and Patient-centered Outcomes Research , 2014, Medical care.

[68]  Mia Gallagher,et al.  Validity of Privacy-Protecting Analytical Methods That Use Only Aggregate-Level Information to Conduct Multivariable-Adjusted Analysis in Distributed Data Networks , 2018, American journal of epidemiology.

[69]  Christian Hampp,et al.  Sentinel Modular Program for Propensity Score–Matched Cohort Analyses: Application to Glyburide, Glipizide, and Serious Hypoglycemia , 2017, Epidemiology.

[70]  M. Tobin,et al.  DataSHIELD: resolving a conflict in contemporary bioscience—performing a pooled analysis of individual-level data without sharing the data , 2010, International journal of epidemiology.

[71]  R. Davis,et al.  Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. , 2007, The New England journal of medicine.

[72]  W Katherine Yih,et al.  Near real‐time vaccine safety surveillance with partially accrued data , 2011, Pharmacoepidemiology and drug safety.

[73]  M. Schuemie,et al.  Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study , 2016, British Medical Journal.

[74]  Y. Alvarez,et al.  Impact of varying outcomes and definitions of suicidality on the associations of antiepileptic drugs and suicidality: comparisons from UK Clinical Practice Research Datalink (CPRD) and Danish national registries (DNR) , 2016, Pharmacoepidemiology and drug safety.

[75]  J. Simeone,et al.  Replication of Mini-Sentinel Study Assessing Mirabegron and Cardiovascular Risk in Non-Mini-Sentinel Databases , 2017, Drugs - Real World Outcomes.

[76]  Murat Kantarcioglu,et al.  A secure distributed logistic regression protocol for the detection of rare adverse drug events , 2012, J. Am. Medical Informatics Assoc..

[77]  Xiaodong Lin,et al.  Secure Regression on Distributed Databases , 2005 .

[78]  D L DeMets,et al.  Interim analysis: the alpha spending function approach. , 1994, Statistics in medicine.

[79]  J. Gagne.  Common Models, Different Approaches , 2015, Drug Safety.

[80]  Richard Platt,et al.  Four health data networks illustrate the potential for a shared national multipurpose big-data network. , 2014, Health affairs.

[81]  Jeffrey S. Brown,et al.  Orphan Therapies: Making Best Use of Postmarket Data , 2014, Journal of General Internal Medicine.

[82]  A. Kesselheim,et al.  Strategies for Postmarketing Surveillance of Drugs for Rare Diseases , 2014, Clinical pharmacology and therapeutics.

[83]  Richard Platt,et al.  The U.S. Food and Drug Administration's Mini‐Sentinel program: status and direction , 2012, Pharmacoepidemiology and drug safety.

[84]  Adrian F Hernandez,et al.  Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system. , 2012, Archives of internal medicine.

[85]  D. Madigan,et al.  Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership , 2012, Statistics in medicine.

[86]  Robert L Davis,et al.  Real-Time Vaccine Safety Surveillance for the Early Detection of Adverse Events , 2007, Medical care.

[87]  Richard Platt,et al.  Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. , 2004, JAMA.

[88]  J. Overhage,et al.  Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes Partnership , 2010, Annals of Internal Medicine.

[89]  Michio Kimura,et al.  Variation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six Countries , 2015, Drug Safety.

[90]  Sengwee Toh,et al.  Design and analysis choices for safety surveillance evaluations need to be tuned to the specifics of the hypothesized drug–outcome association , 2016, Pharmacoepidemiology and drug safety.

[91]  Robert W. Platt,et al.  Observational Studies of Drug Safety in Multi-Database Studies: Methodological Challenges and Opportunities , 2016, EGEMS.

[92]  R. Platt,et al.  The new Sentinel Network--improving the evidence of medical-product safety. , 2009, The New England journal of medicine.

[93]  Douglas G. Altman,et al.  Analysing Data and Undertaking Meta‐Analyses , 2019 .

[94]  E. Roughead,et al.  Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study , 2016, British Medical Journal.

[95]  Characteristics of study design and elements that may contribute to the success of electronic safety monitoring systems , 2014, Pharmacoepidemiology and drug safety.

[96]  J. Gagne,et al.  Safety assessment of niacin in the US Food and Drug Administration's mini‐sentinel system , 2018, Pharmacoepidemiology and drug safety.

[97]  Sebastian Schneeweiss,et al.  Multivariate‐adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases , 2010, Pharmacoepidemiology and drug safety.

[98]  R. Platt,et al.  Distributed Health Data Networks: A Practical and Preferred Approach to Multi-Institutional Evaluations of Comparative Effectiveness, Safety, and Quality of Care , 2010, Medical care.

[99]  N. Pratt,et al.  The Asian Pharmacoepidemiology Network (AsPEN): promoting multi‐national collaboration for pharmacoepidemiologic research in Asia , 2013, Pharmacoepidemiology and drug safety.

[100]  S. Fienberg,et al.  Secure multiple linear regression based on homomorphic encryption , 2011 .

[101]  A. Levy,et al.  CNODES: the Canadian Network for Observational Drug Effect Studies , 2012, Open medicine : a peer-reviewed, independent, open-access journal.

[102]  Clay Shirky,et al.  Collecting and sharing data for population health: a new paradigm. , 2009, Health affairs.